Business · 13/09/2012
FDA Hosts Public Workshop on Glaucoma Imaging Devices with American Glaucoma Society
The Food and Drug Administration (FDA) is hosting a public workshop to discuss the validity, reliability, and usability of glaucoma imaging devices, with a focus on Optical Coherence Tomography (OCT) and its application in clinical practice.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →